Table Of Contents
1 Introduction 18
1.1 Objectives Of The Study 18
1.2 Market Definition 18
1.3 Overview Of Global Clinical Trial Supplies Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 DBMR Market Challenge Matrix 30
2.8 Secondary Sources 31
2.9 Assumptions 31
3 Market Overview 32
3.1 Drivers 34
3.1.1 Rising Demand Of Clinical Trials Worldwide 34
3.1.2 Increasing Incidences Of Diseases 35
3.1.3 Government Funds To R&D Investments 36
3.1.4 Development Of New Treatments Such As Personalized Medicine 36
3.2 Restraints 37
3.2.1 Adverse Effects Of Clinical Trials 37
3.2.2 Transportation Issue 37
3.3 Opportunities 38
3.3.1 New Drug Development And Availability In Emerging Countrires 38
3.4 Challenges 39
3.4.1 Longer Procedure Time Of Clinical Trials Approval 39
4 Executive Summary 40
5 Premium Insights 43
?
6 Global Clinical Trial Supplies Market, By Services 46
6.1 Overview 47
6.2 Storage 49
6.3 Manufacturing 51
6.4 Packaging And Labeling 52
6.5 Distribution 54
7 Global Clinical Trial Supplies Market, By Clinical Phases 55
7.1 Overview 56
7.2 Phase Iii 58
7.3 Phase Ii 59
7.4 Phase Iv 60
7.5 Phase I 61
8 Mjkglobal Clinical Trial Supplies Market, By Therapeutic Use 63
8.1 Overview 64
8.2 Oncology 66
8.3 Cardiovascular Disease 68
8.4 Dermatology 69
8.5 Metabolic Disorders 70
8.6 Infectious Disease 71
8.7 Respiratory Diseases 72
8.8 Cns And Mental Disorders 73
8.9 Blood Disorders 74
8.10 Others 75
9 Global Clinical Trial Supplies Market, By End User 76
9.1 Overview 77
9.2 Contract Research Organizations 79
9.3 Pharmaceutical And Biotechnology Companies 80
10 Global Clinical Trial Supplies Market, By Geography 82
10.1 Overview 83
10.2 North America 88
10.2.1 U.S. 95
10.2.2 Canada 98
10.2.3 Mexico 100
10.3 Europe 102
10.3.1 Germany 109
10.3.2 France 111
10.3.3 U.K. 113
10.3.4 Italy 115
10.3.5 Spain 117
10.3.6 Netherlands 119
10.3.7 Russia 121
10.3.8 Belgium 123
10.3.9 Turkey 125
10.3.10 Switzerland 127
10.3.11 Rest Of Europe 129
10.4 Asia-Pacific 130
10.4.1 China 138
10.4.2 Japan 140
10.4.3 India 142
10.4.4 South Korea 144
10.4.5 Australia 146
10.4.6 Thailand 148
10.4.7 Malaysia 150
10.4.8 Singapore 152
10.4.9 Indonesia 154
10.4.10 Philippines 156
10.4.11 Rest Of Asia-Pacific 158
10.5 South America 159
10.5.1 Brazil 166
10.5.2 Rest Of South America 168
10.6 Middle East & Africa 169
10.6.1 South Africa 176
10.6.2 Rest Of Middle East & Africa 178
11 Global Clinical Trial Supplies Market, Company Landscape 179
11.1 Company Share Analysis; Global 179
11.2 Company Share Analysis; North America 180
11.3 Company Share Analysis; Europe 181
11.4 Company Share Analysis; Asia-Pacific 182
12 Company Profile 183
12.1 Thermo Fisher Scientific Inc. 183
12.1.1 Company Overview 183
12.1.2 Revenue Analysis 183
12.1.3 Company Share Analysis 184
12.1.4 Product Portfolio 184
12.1.5 Recent Developments 185
12.2 Catalent, Inc.186
12.2.1 Company Overview 186
12.2.2 Revenue Analysis 186
12.2.3 Company Share Analysis 187
12.2.4 Product Portfolio 187
12.2.5 Recent Developments 188
12.3 Clinigen Group Plc. 189
12.3.1 Company Overview 189
12.3.2 Revenue Analysis 189
12.3.3 Revenue Analysis 190
12.3.4 Product Portfolio 190
12.3.5 Recent Developments 190
12.4 Parexel International Corporation 191
12.4.1 Company Overview 191
12.4.2 Revenue Analysis 191
12.4.3 Company Share Analysis 192
12.4.4 Product Portfolio 192
12.4.5 Recent Developments 192
12.5 Alium Medical Limited 193
12.5.1 Company Overview 193
12.5.2 Product Portfolio 193
12.5.3 Recent Developments 193
12.6 Almac Group 194
12.6.1 Company Overview 194
12.6.2 Geographic Presence 194
12.6.3 Product Portfolio 195
12.6.4 Recent Developments 195
12.7 Ancillare, Lp 196
12.7.1 Company Overview 196
12.7.2 Geographic Presence 196
12.7.3 Product Portfolio 197
12.7.4 Recent Developments 197
12.8 Biocair 198
12.8.1 Company Overview 198
12.8.2 Product Portfolio 198
12.8.3 Recent Developments 198
12.9 Bionical Ltd. 199
12.9.1 Company Overview 199
12.9.2 Gepographic Presence 199
12.9.3 Product Portfolio 200
12.9.4 Recent Developments 200
12.10 Clinical Supplies Management Holdings, Inc. 201
12.10.1 Company Overview 201
12.10.2 Geographic Presence 201
12.10.3 Product Portfolio 202
12.10.4 Recent Developments 202
12.11 Klifo 203
12.11.1 Company Overview 203
12.11.2 Geographic Presence 203
12.11.3 Product Portfolio 204
12.11.4 Recent Developments 204
12.12 Movianto 205
12.12.1 Company Overview 205
12.12.2 Geographic Presence 205
12.12.3 Product Portfolio 206
12.12.4 Recent Developments 206
12.13 Myoderm 207
12.13.1 Company Overview 207
12.13.2 Geographic Presence 207
12.13.3 Product Portfolio 208
12.13.4 Recent Developments 208
12.14 Pci Pharma Services 209
12.14.1 Company Overview 209
12.14.2 Geographic Presence 209
12.14.3 Product Portfolio 210
12.14.4 Recent Developments 210
12.15 Sharp 211
12.15.1 Company Overview 211
12.15.2 Geographic Presence 211
12.15.3 Product Portfolio 212
12.15.4 Recent Developments 213
12.16 Siro Clinpharm 214
12.16.1 Company Overview 214
12.16.2 Geographic Presence 214
12.16.3 Product Portfolio 215
12.16.4 Recent Developments 215
13 Related Reports 216
?